468 related articles for article (PubMed ID: 11439325)
1. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC
Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.
Sirma H; Giannini C; Poussin K; Paterlini P; Kremsdorf D; Bréchot C
Oncogene; 1999 Aug; 18(34):4848-59. PubMed ID: 10490818
[TBL] [Abstract][Full Text] [Related]
3. Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance.
Chen WN; Oon CJ; Leong AL; Koh S; Teng SW
Biochem Biophys Res Commun; 2000 Oct; 276(3):885-92. PubMed ID: 11027564
[TBL] [Abstract][Full Text] [Related]
4. COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis.
Cheng AS; Yu J; Lai PB; Chan HL; Sung JJ
Biochem Biophys Res Commun; 2008 Sep; 374(2):175-80. PubMed ID: 18601905
[TBL] [Abstract][Full Text] [Related]
5. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene.
Wang XW; Gibson MK; Vermeulen W; Yeh H; Forrester K; Stürzbecher HW; Hoeijmakers JH; Harris CC
Cancer Res; 1995 Dec; 55(24):6012-6. PubMed ID: 8521383
[TBL] [Abstract][Full Text] [Related]
8. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Bréchot P; Bréchot C; Kremsdorf D
Cancer Res; 2001 Nov; 61(21):7803-10. PubMed ID: 11691796
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF
Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437
[TBL] [Abstract][Full Text] [Related]
10. [Biological impact of the COOH-terminal 40 amino acid deletions of hepatitis B virus X protein in hepatocellular carcinoma cells].
Liu XH; Lin J; Cao XZ; Zheng JM; Chen Y; Zhu MH
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):825-30. PubMed ID: 15949399
[TBL] [Abstract][Full Text] [Related]
11. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma.
Chen GG; Li MY; Ho RL; Chak EC; Lau WY; Lai PB
J Clin Virol; 2005 Sep; 34(1):7-12. PubMed ID: 16087118
[TBL] [Abstract][Full Text] [Related]
12. Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation.
Zhang H; Shan CL; Li N; Zhang X; Zhang XZ; Xu FQ; Zhang S; Qiu LY; Ye LH; Zhang XD
Acta Pharmacol Sin; 2008 Apr; 29(4):473-80. PubMed ID: 18358094
[TBL] [Abstract][Full Text] [Related]
13. Molecular functions and biological roles of hepatitis B virus x protein.
Tang H; Oishi N; Kaneko S; Murakami S
Cancer Sci; 2006 Oct; 97(10):977-83. PubMed ID: 16984372
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression.
Kim SY; Kim JK; Kim HJ; Ahn JK
IUBMB Life; 2005 Sep; 57(9):651-8. PubMed ID: 16203685
[TBL] [Abstract][Full Text] [Related]
15. The cysteine residues of the hepatitis B virus onco-protein HBx are not required for its interaction with RNA or with human p53.
de Moura PR; Rui E; de Almeida Gonçalves K; Kobarg J
Virus Res; 2005 Mar; 108(1-2):121-31. PubMed ID: 15681062
[TBL] [Abstract][Full Text] [Related]
16. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis.
Ma NF; Lau SH; Hu L; Xie D; Wu J; Yang J; Wang Y; Wu MC; Fung J; Bai X; Tzang CH; Fu L; Yang M; Su YA; Guan XY
Clin Cancer Res; 2008 Aug; 14(16):5061-8. PubMed ID: 18698024
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249.
Oguey D; Dumenco LL; Pierce RH; Fausto N
Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370
[TBL] [Abstract][Full Text] [Related]
18. TP53 and liver carcinogenesis.
Staib F; Hussain SP; Hofseth LJ; Wang XW; Harris CC
Hum Mutat; 2003 Mar; 21(3):201-16. PubMed ID: 12619106
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes.
Uchida T; Takahashi K; Tatsuno K; Dhingra U; Eliason JF
Int J Cancer; 1996 Sep; 67(6):892-7. PubMed ID: 8824564
[TBL] [Abstract][Full Text] [Related]
20. [Biological effects of COOH-terminal amino acid deletions of hepatitis B virus X protein on hepatocellular carcinoma cell line Huh7].
Liu XH; Zhu MH; Cao XZ; Zheng JM; Chen Y
Ai Zheng; 2005 Oct; 24(10):1213-9. PubMed ID: 16219135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]